NYSE · APDMaterialsIndustrial Chemicals

Air Products & Chemicals financials

$278.75−1.07%
Close Sep 28, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ3 '26
Jun 30
Q2 '26
Mar 31
Q1 '26
Dec 31
Q4 '25
Sep 30
Q3 '25
Jun 30
Q2 '25
Mar 31
Q1 '25
Dec 31
Q4 '24
Sep 30
Q3 '24
Jun 30
Q2 '24
Mar 31
Q1 '24
Dec 31
Q4 '23
Sep 30
Revenue$3.16B$3.17B$3.10B$3.17B$3.02B$2.92B$2.93B$3.19B$2.99B$2.93B$3.00B$3.19B
Gross profit$1.04B$987.4M$995.0M$1.02B$982.6M$862.3M$915.0M$1.08B$979.9M$938.7M$930.2M$984.1M
Gross margin32.8%31.1%32.1%32.3%32.5%29.6%31.2%34.0%32.8%32.0%31.0%30.8%
Operating income-$2.10B$752.7M$734.5M-$50.5M$723.3M-$2.33B$643.6M$848.8M$737.6M$637.2M$666.9M$703.8M
Net income-$1.44B$710.4M$678.2M$4.9M$713.8M-$1.73B$617.4M$1.95B$696.6M$572.4M$609.3M$692.6M
Net margin−45.6%22.4%21.9%0.2%23.6%−59.3%21.1%61.2%23.3%19.5%20.3%21.7%
Diluted EPS$-6.47$3.19$3.04$0.02$3.20$-7.77$2.77$8.75$3.13$2.57$2.73$3.11
EBITDA$1.20B$1.13B$1.13B$1.16B$1.15B$983.5M$1.01B$1.23B$1.10B$1.05B$1.02B$703.8M
Operating cash flow$1.31B$1.10B$900.7M$1.26B$855.8M$328.1M$811.7M$957.0M$1.26B$801.7M$626.6M$1.00B
Free cash flow$309.5M-$3.9M-$350.5M-$256.5M-$640.0M-$1.56B-$1.31B-$1.12B-$345.2M-$867.7M-$818.9M-$460.0M
Diluted shares222.8M222.9M222.9M222.2M222.9M222.8M222.9M222.9M222.8M222.7M222.8M222.7M

Balance sheet

Period endJun 30Mar 31Dec 31Sep 30Jun 30Mar 31
Cash & equivalents$980.5M$951.0M$1.03B$1.86B$2.32B$1.49B
Short-term investments$0.00$0.00$0.00$0.00$0.00$111.4M
Total debt$17.67B$17.76B$17.53B$17.70B$17.69B$15.86B
Total assets$40.45B$41.64B$41.24B$41.06B$41.66B$38.87B
Total liabilities$23.85B$23.49B$23.40B$23.71B$23.89B$22.09B
Shareholders' equity$16.60B$18.15B$17.84B$17.35B$17.77B$16.78B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology